BlueLinx Announces Expansion of Distribution Partnership with LP Building Solutions — Neutral
BXC LPX Business Wire — June 02, 2025ATLANTA--(BUSINESS WIRE)--BlueLinx Holdings Inc. (NYSE: BXC), a leading U.S. wholesale distributor of building products, and Louisiana-Pacific Corporation (LP Building Solutions, NYSE: LPX), a leading manufacturer of engineered wood building products, are pleased to announce the expansion of their distribution partnership to Springfield, Missouri. The expanded collaboration will include LP's renowned Siding Solutions brands and prefinished solutions, namely LP® SmartSide® Trim & Siding and.

Charles River Laboratories to Present at William Blair and Jefferies Conferences — Neutral
CRL Business Wire — June 02, 2025WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at William Blair and Jefferies Conferences.

Redfin Reports U.S. Home Sellers Are Sitting on $700 Billion Worth of Listings, an All-Time High — Neutral
RDFN Business Wire — June 02, 2025SEATTLE--(BUSINESS WIRE)--(NASDAQ: RDFN) — There's a total of $698 billion worth of homes for sale in the U.S., up 20.3% from a year ago and the highest dollar amount ever, according to a new report from Redfin (redfin.com), the technology-powered real estate brokerage. The report is based on an analysis of listings on Redfin.com going back through 2012. For the total dollar value of all inventory on the market, Redfin summed up the list price of all active U.S. listings as of the last day of e.

Homeownership Aspirations Remain Strong as Americans Highlight an Opportunity for More Support — Neutral
KBH Business Wire — June 02, 2025LOS ANGELES--(BUSINESS WIRE)-- #BuiltOnRelationships--KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today announced the findings of its second annual survey, which the company conducted to gauge Americans' sentiments about homeownership and support their homebuying aspirations. New data released found that most Americans still believe that homeownership is an important milestone (83%), but an even greater number feel anxious (89%) about affordability and the homebuying process. Jun.

Diversified Healthcare Trust Closes $94 Million of Mortgage Financings Secured by Six SHOP Communities — Neutral
DHC Business Wire — June 02, 2025NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it has closed two fixed rate mortgage financings totaling $94.3 million, secured by six senior housing communities managed by Five Star Senior Living, the operating division of AlerisLife Inc. The financings consist of a $64.0 million five-year mortgage loan and a $30.3 million ten-year Fannie Mae mortgage loan. Proceeds from these loans, together with cash on hand, will be used to repay the remainin.

Solésence Expands Debt Facilities to Fuel Growth Initiatives — Neutral
SLSN GlobeNewsWire — June 02, 2025ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it entered into amendments on May 27, 2025 to its existing loan agreements, providing increased borrowing capacity to support the execution of strategic objectives.

Lineage, Inc. Announces Chief Financial Officer Retirement and Transition Plan — Neutral
LINE Business Wire — June 02, 2025NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-controlled warehouse REIT, today announces the planned retirement of its Chief Financial Officer, Rob Crisci. The Company has started the process of identifying a successor for the position with the assistance of a leading executive search firm. Crisci will continue as CFO until a successor is in place and will remain with Lineage through a subsequent transition period. “On behalf.

General Mills and Lactalis Receive Regulatory Clearance for U.S. Yogurt Transaction — Neutral
GIS Business Wire — June 02, 2025MINNEAPOLIS--(BUSINESS WIRE)--General Mills, Inc. (NYSE: GIS) and Lactalis today announced that the regulatory review for the sale of General Mills' U.S. Yogurt business to Lactalis is complete, and the transaction is cleared to close subject to completion of other customary closing conditions. The companies are targeting to complete the transaction in late June 2025. About General Mills General Mills makes food the world loves. The company is guided by its Accelerate strategy to boldly build i.

FICO Drives Financial Empowerment at Professional Golf Tournaments Across North America — Neutral
FICO Business Wire — June 02, 2025BOZEMAN, Mont.--(BUSINESS WIRE)---- $FICO--Global analytics software company FICO will be showcasing Score A Better Future™ Fundamentals (Fundamentals), a free credit education program for high-school-aged students, through a series of golf events this summer. As a part of its successful, nation-wide Score A Better Future (SABF) financial education program, FICO designed Fundamentals to empower teens to be better prepared for their financial futures with the knowledge and tools to help them make more res.

FCP CLOSES $13.25 MILLION IN PREFERRED EQUITY FOR 333-UNIT MULTIFAMILY DEVELOPMENT IN POOLER, GA — Neutral
OZK PRNewsWire — June 02, 2025CHEVY CHASE, Md. , June 2, 2025 /PRNewswire/ -- FCP® has closed on a $13.25 million preferred equity investment through its Structured Investments platform to finance Mosaic Pooler , a 333-unit, Class A multifamily development on Old Quacco Road in the dynamic Savannah submarket of Pooler, GA.

Marriott International Celebrates Outstanding 25-Year Leadership in Branded Residences with Around 300 Projects in Open & Pipeline Portfolio — Neutral
MAR PRNewsWire — June 02, 2025Marriott bolsters industry's largest residential portfolio with several signed agreements in desirable destinations around the world. NEW YORK , June 2, 2025 /PRNewswire/ -- Today, Marriott International, Inc. (Nasdaq: MAR), the industry leader in branded residential development, announces signed agreements in: Detroit, Michigan ; Muskoka, Canada; Gulf of Papagayo, Guanacaste, Costa Rica; and Jeddah, Saudi Arabia ; bringing the Marriott Branded Residences total open and pipeline portfolio to around 300 projects.

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer — Neutral
WAT PRNewsWire — June 02, 2025News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench space than other products in its class.2 Takes the industry-leading sensitivity of Xevo TQ Absolute to new heights, including for PFAS detection and pharma quantitation applications. BALTIMORE and MILFORD, Mass.

Lyntia Networks Accelerates Automation with Oracle Unified Operations — Neutral
ORCL PRNewsWire — June 02, 2025Spanish service provider transforms key processes to enhance business agility and service delivery with Oracle Communications and Optare Solutions AUSTIN, Texas and MADRID , June 2, 2025 /PRNewswire/ -- Lyntia Networks, a leading neutral operator in the wholesale telecom sector, is relying on Oracle solutions to help meet its ambitious growth in the highly competitive infrastructure and connectivity markets. The operator is leveraging the out-of-the-box capabilities of Oracle Communications cloud native solutions to transform its operational support systems (OSS), enabling faster service delivery through automated orchestration processes.

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting — Neutral
SLS GlobeNewsWire — June 02, 2025- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced preclinical efficacy of SLS009 (tambiciclib) in ASXL1 mutated colorectal cancer lines. The data are featured in a presentation, entitled “In vitro efficacy of CDK9 …

STMicroelectronics Announces Status of Common Share Repurchase Program — Neutral
STM GlobeNewsWire — June 02, 2025STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 26, 2025 to May 30, 2025 AMSTERDAM – June 2, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the “Program”) disclosed via a press release dated June 21, 2024.

Harmonic's cOS Broadband Platform Enables World's First PTP-less Deployment to Fuel Vectra's Network Transformation and Enable Wholesale Fiber and DOCSIS Offerings SAN JOSE, Calif. , June 2, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced that Vectra, one of the largest internet providers in Poland, has selected Harmonic's industry-leading cOS™ virtualized broadband platform to accelerate its multigigabit broadband service expansion, enable selective migration to deep fiber infrastructure and power its new wholesale fiber and DOCSIS offerings.

Wyndham's First-Annual Owner Trends Report Highlights Positive Long-Term Outlook, Vital Role of Brands — Neutral
WH PRNewsWire — June 02, 2025Hotel owners and property developers remain confident in industry's resiliency despite a news cycle dominated by tariffs, inflation, interest rates and more PARSIPPANY, N.J. , June 2, 2025 /PRNewswire/ -- Wyndham Hotels & Resorts today unveiled its first-annual Hotel Owner Trends Report.

Opus Genetics Announces LYNX-2 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients with Visual Disturbances Under Mesopic, Low-Contrast Conditions — Neutral
IRD GlobeNewsWire — June 02, 2025Study met primary endpoint of ≥15-letter (≥3-line) gain in mesopic low contrast distance visual acuity in comparison to placebo Phase 3 study showed patient-reported functional benefit in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision, a condition with no current FDA-approved therapies Safety profile consistent with previous studies, with no new safety signals identified No evidence of tachyphylaxis was observed in this study over the 6-week period Study was conducted under FDA Special Protocol Assessment and Fast-Track Designation RESEARCH TRIANGLE PARK, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage …

ASML reports transactions under its current share buyback program — Neutral
ASML GlobeNewsWire — June 02, 2025ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.

BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen — Neutral
BCAB GlobeNewsWire — June 02, 202545% overall response rate (ORR) and a 100% disease control rate (DCR) in HPV+ OPSCC patients treated with a median of 3 prior lines of therapy Marked unmet need exists in 2L+ HPV+ OPSCC patients; standard of care agents (methotrexate, docetaxel, or cetuximab) report an ORR of 3.4% Plan to finalize Phase 3 trial design in 2L+ HPV+ OPSCC with the U.S. Food and Drug Administration (FDA) SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment …
